Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1822]
News [2727]
Articles [201]
Editorials [1]
Conferences [136]
elearning [13]
How to decide the treatment of CLL in 2015
Dr Marco Montillo and Dr Maria Gomes da Silva
How to decide the treatment of CLL in 2015 ( Dr Marco Montillo and Dr Maria Gomes da Silva )
24 Apr 2015
ecancermedicalscience editor's choice for February 2015
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience editor's choice for February 2015 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
3 Mar 2015
Effectiveness of adjuvant chemotherapy on patients with bladder cancer
Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA
Effectiveness of adjuvant chemotherapy on patients with bladder cancer ( Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA )
2 Mar 2015
ASCO GU 2015 news roundup
Peter Goodwin - ecancer correspondent, London, UK
ASCO GU 2015 news roundup ( Peter Goodwin - ecancer correspondent, London, UK )
28 Feb 2015
Taxane response in prostate cancer may not be influenced by androgen receptor...
Dr Emmanuel Antonarakis - Johns Hopkins School of Medicine, Baltimore, USA
Taxane response in prostate cancer may not be influenced by androgen receptor variations ( Dr Emmanuel Antonarakis - Johns Hopkins School of Medicine, Baltimore, USA )
28 Feb 2015
Expert commentary on emerging research in genitourinary cancer
Dr Chris Parker - The Royal Marsden Hospital, London, UK
Expert commentary on emerging research in genitourinary cancer ( Dr Chris Parker - The Royal Marsden Hospital, London, UK )
28 Feb 2015
Combination of dalantercept plus axitinib versus placebo plus axitinib in...
Dr Martin Voss - Memorial Sloan Kettering Cancer Centre, New York City, USA
Combination of dalantercept plus axitinib versus placebo plus axitinib in advanced clear cell renal cell carcinoma ( Dr Martin Voss - Memorial Sloan Kettering Cancer Centre, New York City, USA )
28 Feb 2015
VEGF targeted therapy and chemo an active combination in rapidly progressive...
Dr Rana McKay - Dana-Farber Cancer Institute, Boston, USA
VEGF targeted therapy and chemo an active combination in rapidly progressive renal cell carcinoma ( Dr Rana McKay - Dana-Farber Cancer Institute, Boston, USA )
27 Feb 2015
Combination of abiraterone and cabazitaxel in metastatic castration-resistant...
Dr Joaquin Mateo - Institute of Cancer Research, London, UK
Combination of abiraterone and cabazitaxel in metastatic castration-resistant prostate cancer ( Dr Joaquin Mateo - Institute of Cancer Research, London, UK )
27 Feb 2015
ASCO GU 2015: Review of the latest data in prostate cancer
Prof Eleni Efstathiou, Prof Charles Ryan, Dr Heather Payne
ASCO GU 2015: Review of the latest data in prostate cancer ( Prof Eleni Efstathiou, Prof Charles Ryan, Dr Heather Payne )
27 Feb 2015
Combination of pazopanib and paclitaxel safe in urothelial cancer
Prof Sandy Srinivas - Stanford University Medical Centre, Stanford, USA
Combination of pazopanib and paclitaxel safe in urothelial cancer ( Prof Sandy Srinivas - Stanford University Medical Centre, Stanford, USA )
26 Feb 2015
Tackling renal cancer with a combination of autologous immunotherapy and...
Prof Robert Figlin - Cedars-Sinai, Los Angeles, USA
Tackling renal cancer with a combination of autologous immunotherapy and sunitinib ( Prof Robert Figlin - Cedars-Sinai, Los Angeles, USA )
26 Feb 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation